您的位置: 首页 > 农业专利 > 详情页

COMBINED USE OF (+)-1,4-DIHYDRO-7-((3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL)-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID AND CYTARABINE (ARA-C) FOR THE TREATMENT OF LEUKEMIA
专利权人:
SUNESIS PHARMACEUTICALS; INC.
发明人:
ADELMAN DANIEL C.,ADELMAN Daniel C.,SILVERMAN JEFFREY A.,SILVERMAN Jeffrey A.,MICHELSON GLENN,MICHELSON Glenn,SCATENA CAROLINE DARNE,SCATENA Caroline Darne
申请号:
SI200731723
公开号:
SI2049109T1
申请日:
2007.08.02
申请国别(地区):
SI
年份:
2016
代理人:
摘要:
Methods of treating, preventing or managing hematologic disorders, such as leukemia are disclosed. The methods encompass the administration of SNS-595. Also provided are methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. In certain embodiments, the method of treatment comprise administering SNS-595 in combination with Ara-C.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充